Nalfurafine is a centrally acting kappa-opioid receptor agonist, and its primary medical use is to treat itching (pruritus) associated with chronic kidney disease. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include (E)-N-[(4R, 4aS, 7R, 7aR, 12bS)-3-(cyclopropylmethyl)-4a, 9-dihydroxy-1, 2, 4, 5, 6, 7, 7a, 13-octahydro-4, 12-methanobenzofuro[3, 2-e]isoquinoline-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide and nalfurafinum. Its PubChem CID is 6445230.
Nalfurafine
| CAS No | 152657-84-6 |
|---|---|
| Molecular Formula | C28H32N2O5 |
| Molecular Weight | 476.6 g/mol |
| Synonyms | (E)-N-[(4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Nalfurafine is a centrally acting kappa-opioid receptor agonist, and its primary medical use is to treat itching (pruritus) associated with chronic kidney disease.
The listed CAS number is 152657-84-6.
The listed molecular formula is C28H32N2O5.
The listed molecular weight is 476.6 g/mol.
(E)-N-[(4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide.
The source lists (E)-N-[(4R, 4aS, 7R, 7aR, 12bS)-3-(cyclopropylmethyl)-4a, 9-dihydroxy-1, 2, 4, 5, 6, 7, 7a, 13-octahydro-4, 12-methanobenzofuro[3, 2-e]isoquinoline-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide and nalfurafinum.